Atara Biotherapeutics, Inc. (ATRA): Cash & Equivalents
$8.48M
As of 2025-12-31
$3.22M
As of 2026-06-30
-55.0%
3-year compound annual growth
-46.9%
5-year compound annual growth
-9.8%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $8.48M | -66.1% | 2026-03-16, Balance as of period end |
| 2024-12-31 | $25.03M | -3.1% | 2026-03-16, Balance as of period end |
| 2023-12-31 | $25.84M | -72.2% | 2025-03-07, Balance as of period end |
| 2022-12-31 | $92.94M | -12.4% | 2024-03-28, Balance as of period end |
| 2021-12-31 | $106.08M | -47.1% | 2023-02-08, Balance as of period end |
| 2020-12-31 | $200.40M | +169.7% | 2022-02-28, Balance as of period end |
| 2019-12-31 | $74.32M | +22.4% | 2021-03-01, Balance as of period end |
| 2018-12-31 | $60.70M | -23.4% | 2020-02-27, Balance as of period end |
| 2017-12-31 | $79.22M | +65.2% | 2019-02-26, Balance as of period end |
| 2016-12-31 | $47.97M | +102.0% | 2018-02-27, Balance as of period end |
| 2015-12-31 | $23.75M | +8.4% | 2018-02-27, Balance as of period end |
| 2014-12-31 | $21.90M | -57.6% | 2017-03-09, Balance as of period end |
| 2013-12-31 | $51.62M | n/m | 2016-03-04, Balance as of period end |
| 2012-12-31 | $4.21M | n/a | 2015-02-26, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Atara Biotherapeutics, Inc. (ATRA) | 2025-12-31 | $8.48M | -66.1% |
| Monte Rosa Therapeutics, Inc. (GLUE) | 2025-12-31 | $129.88M | -42.1% |
| Agenus Inc (AGEN) | 2025-12-31 | $3.00M | -92.6% |
| ImmunityBio, Inc. (IBRX) | 2025-12-31 | $88.33M | -38.4% |
| Century Therapeutics, Inc. (IPSC) | 2025-12-31 | $61.85M | +5.8% |
| Beam Therapeutics Inc. (BEAM) | 2025-12-31 | $294.94M | +4.6% |
| Sutro Biopharma, Inc. (STRO) | 2025-12-31 | $58.13M | -69.5% |
| Ginkgo Bioworks Holdings, Inc. (DNA) | 2025-12-31 | $167.20M | -70.2% |
| REGENXBIO Inc. (RGNX) | 2025-12-31 | $34.47M | -40.1% |
Compare ATRA, GLUE, AGEN, IBRX side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗